Tradestie Institutional Equity Comparison Engine
BOLD vs AVTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BOLD Overall Edge
BOLD Captures Institutional Edge (3โ0 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boundless Bio, Inc. Common Stock (BOLD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BOLD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AVTX at N/M Forward P/E and -161962.7% operating margin (-69.3% YoY). In options structure, BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AVTX sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BOLD N/M vs AVTX N/M Fwd P/E
Growth & Margin Winner
BOLD
Op Margin 0.0% vs -161962.7% ยท YoY +0.0% vs -69.3%
Momentum & Technical Winner
BOLD
1Y +101.7% vs -61.6% ยท 52W Pos 62% vs 1%
Options & Structure Winner
BOLD
UNCLASSIFIED (N/A IV) vs BREAKDOWN (15th %ile IV)
BOLD
NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap
$56.2M
1M Return
-4.92%
1Y Return
+101.74%
Forward P/E
N/M
Unified AI Score
36.8 / 100
SELL
Tech 25.0
Fund 50.0
Flow 50.0
Mom 60.0
AVTX
NASDAQ
Avalo Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$6.76
+0.15% 1D
Market Cap
$390.3M
1M Return
-9.26%
1Y Return
-61.57%
Forward P/E
N/M
Unified AI Score
45.6 / 100
HOLD
Tech 39.0
Fund 61.0
Flow 68.0
Mom 68.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BOLD +101.74%
AVTX -61.57%
Spread: +163.31 pp (BOLD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BOLD TTM Op. Margin: 0.0%
AVTX TTM Op. Margin: -161962.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BOLD vs AVTX. Trailing 12-month operating profitability (BOLD 0.0% vs AVTX -161962.7%) and valuation multiples (BOLD N/M vs AVTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BOLD | AVTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $56.2M | $390.3M | Larger Scale | AVTX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -69.3% | Higher Growth | BOLD |
| Operating Margin (TTM) Profitability | 0.0% | -161962.7% | Higher Margin | BOLD |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -64.6% | -33.6% | Higher ROE | AVTX |
| 52-Week Range Position Momentum | 62% ($1โ$3) | 1% ($7โ$24) | Stronger Trend | BOLD |
| Beta / 30D Volatility Risk Regime | -0.08ฮฒ ยท 28% Vol | 1.54ฮฒ ยท 94% Vol | Lower Realized Risk | BOLD |
| Unified Institutional Score Composite Signal | 36.8 / 100 (SELL) | 45.6 / 100 (HOLD) | Higher Composite | AVTX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BOLD vs AVTX Buy Guide
BOLD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AVTX
BREAKDOWN
137d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BOLD nor AVTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.